To track your gifted subscription, go to your Account Settings 
We’ve emailed your gift link. Want us to send some more?
0 of 0 Subscription available
Not now, thanks
FILTERS
Grocery lost, quick commerce gone; yet, Amazon’s three healthcare bets still won’t shift gears
The nearly 30-year-old Sahyadri Hospitals has seen three owners change hands so far. Yet, it’s profitable, trusted among patients, and is a steal for new bidders
A stake in Manipal Cigna or any standalone insurer may just be the start. LIC is bringing government-grade momentum into a market long plagued by low trust, high premiums, and half-hearted reform
Like Zydus, which has had a separate consumer business for years, many pharma companies are chasing newer, better, easier profits
Mental health care is broken, and so is its business model. Wysa thinks it has a fix—starting with the US
The 14-year-old holding company of the 67-year-old listed subsidiary is a canny story of private-equity money birthing a market leader. Dr Agarwal’s Healthcare debuts on the stock market today
Despite counting the Tatas, Reliance, and Mayo Clinic among its investors, Karkinos couldn’t stay afloat long. Its journey was too fast too soon
Despite its high costs, thousands of Indians are opting for digital therapeutics to manage their migraines better and monitor heart health
PE-backed oncology chain HCG is changing hands, and investors haven’t been kind to the stock. But founder BS Ajaikumar won’t let either distract him from his “focused factory” approach
D2C sexual-wellness brands check the missing boxes—bring discreetness, health advice, and urgency. Quick-commerce firms help them sell
Seniors pay 5X the premium for just a fifth of the coverage in critical medical cases. Ayushman Bharat’s new Rs 5 lakh health cover for those over 70 aims to fix that
Pharma software firms like Evitalrx and Marg ERP, and their catalogues of over 400,000 products, are the key to relieving the country of its overcharging problem
Matchmaking between cash-strapped hospitals and the booming insurance market, startups like Gmoney and Digisparsh are chasing the 10 million patients seeking reimbursements
With 18 buyout deals and counting, PE firms' hunger for Indian healthcare assets will only increase. State and central governments are increasingly choosing to become just payers, but they can’t afford to be onlookers
Here’s how you can make sure you don’t pay the price for that
The insurtech unicorn’s upcoming stock-market listing rides on zagging into the lucrative but challenging world of group health insurance while the industry mostly zigs in retail
Hospitals and insurers lock horns over who should bear the cost of expensive robotic surgeries, leaving patients in the dark
A loosening regulatory grip sends insurance prices soaring. Insurers point fingers at rising medical costs, but hospitals aren't buying into it
It started as an aggregator, turned into a diagnostics firm within six months, and ultimately set up its own labs—because some models just don’t cut it in healthcare
“Most cardiac treatment today is acute. But it needn’t be that way… You don’t have to wait till you collapse to get your diagnosis. We can even catch an episode in the middle of the night”
Limiting the number of nurses allowed to work overseas is just one of the new policies trying to solve a supply problem. But, economists contend that the solution lies somewhere else
A three-way merger is about to create the Philippines’ largest telehealth group—KonsultaMD. Their parents? A telco giant and a multibillion-dollar conglomerate
The pandemic was a blessing in disguise for Singapore-based Doctor Anywhere. But virtual care as a stand-alone solution is no longer viable. Now the country’s best-funded startup is adding verticals to its business to stay relevant
With a ‘full-stack’ model, the once healthtech-only player is going up against both established private hospitals and other healthtech startups. While an omnichannel play could work long-term, Jio Health needs to master at least one offering
A paradigm shift in healthcare needs and consumer behaviour has changed the game for medical tourism. For healthcare expert Ruben Toral, who had a front-row seat to Southeast Asia’s medical travel boom in the last two decades, finding a new course for growth will be the new challenge once the pandemic subsides
The Jenga tower of acquisitions at PharmEasy seems to be just that—precariously stacked to look tall. Integrating them in any meaningful way is not for the faint-hearted, nor is its upcoming $1 billion IPO, where it desires to be valued at $8-9 billion
A landmark law and the pandemic served as a catalyst for the growth of mental health-focused teleconsulting startups like InfinitCare and Mind You in the Philippines. However, they’re still grappling with a low supply of mental health professionals and the stigma around the topic, despite a rise in corporate clients
By 2030, almost 24% of Singapore will be over 65 years of age; the eldercare market is projected to cross US$72 billion. And the pandemic has only increased the market opportunity by throwing homecare into the mix. Singapore's govt is now playing catch up to this new, albeit expensive, demand
India needs a plan to inoculate its 1.3 billion citizens against Covid-19. But not only is the app at the centre of it all—CoWIN—glitchy, unpredictable, it is also sparking serious privacy concerns
Varma has just closed two funds, US$600M and US$150M, has deals in the works, and is taking a huge bet on South and Southeast Asia. A regional market, he believes, will be bigger than the US and EU market combined. The secret sauce in his fundraising and deal-making is, well, not so much a secret
India’s largest dialysis chain entered the Philippines by acquiring a 51% stake in local dialysis chain RCDC. The first step in its Pan-Asia expansion, the NephroPlus-RCDC combine must tackle domestic competitors, a dubious national insurer, and a shortage of healthcare staff, all while keeping costs down
In two years, Pristyn has done over 10,000 surgeries across more than a dozen cities. All without running a single hospital
For the past three years, Practo has seen younger players Curefit and HealthifyMe galloping ahead in its unicorn dream. But Covid has secured the healthcare platform government recognition, a surge in users, and a hush-hush $32 million down round
PPE production in India went from zero to 450,000 kits per day in less than three months; the emphasis is now on quality. But creating a product-market fit for the pandemic won’t be as quick or easy
SigTuple's low-cost device and AI tools were all set to speed up diagnostics in India. But an attempt at diversification resulted in an ill-advised foray into an immature direct-to-consumer diagnostics market
An alliance of Indian startups—led by Cure.fit, Practo, and 1mg—in collaboration with iSpirt are looking to create the tele-medicine platform to end all tele-medicine platforms. It's the 'UPI of healthcare', except healthcare is no payments
Occupancy ratios falling by nearly 80%. Dipping revenues. Rationed PPE. Hospitals are in the frontline in the fight against Covid-19, but they might also turn out to be its first casualty.
It seems Indonesia sees 500,000 "less accurate" rapid tests in hand as better than 10,000/day "gold standard" PCR tests in the bush. But that's not the Covid-19 approach the WHO recommends. At least not for patient care
There’s a palpable sense of fear following Covid-19. Businesses are spending less. VCs are waiting and watching. Startups have reported drops in their toplines ranging from 5% to 50% in under a week
From the world’s largest government health insurance scheme to a digital revolution, India’s healthcare sector saw tectonic changes
By continuing, you agree to our Terms of Service and Privacy Policy
“There's no greater gift than thinking that you had some impact on the world, for the better.”
– Gloria Steinem
Our anti-piracy system has flagged your account for suspicious activity and has temporarily paused your account. This may happen due to a number of reasons.
If you think that this was done in error, please get in touch with us at [email protected].
